PaldalGu SuwonSi

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease	HR+/HER2- Breast Cancer	Recruiting	Phase 3	2026-09-28	NCT07492641
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors	Advanced Solid Tumor	Recruiting	Phase 1	2026-09-14	NCT06589596
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors	Advanced Solid Tumor	Recruiting	Phase 1	2026-09-11	NCT06598800
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2026-04-15	NCT05635708

Clinical trials